This research followed prior work in rodent models, and was found to reduce alcohol consumption by half. The drug could also be used to treat diseases like cirrhosis, though the researchers noted that for both applications future research is needed. The general public, policymakers, and other stakeholders need to understand that this type of research is not only necessary, but also normal. Kudos to BBRF — we hope that they will continue these types of clear communications and that other organizations will follow suit. ~Speaking of ResearchOriginal research article:Flippo et al., 2022, FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit.

Source: The Guardian May 31, 2022 16:08 UTC